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Background: The workplace represents a unique setting for mental health interventions. Due to range of job-related factors,
employees in male-dominated industries are at an elevated risk. However, these at-risk groups are often overlooked. HeadGear
is a smartphone app–based intervention designed to reduce depressive symptoms and increase well-being in these populations.
Objective: This paper presents the development and pilot testing of the app’s usability, acceptability, feasibility, and preliminary
effectiveness.
Methods: The development process took place from January 2016 to August 2017. Participants for prototype testing (n=21;
stage 1) were recruited from industry partner organizations to assess acceptability and utility. A 5-week effectiveness and feasibility
pilot study (n=84; stage 2) was then undertaken, utilizing social media recruitment. Demographic data, acceptability and utility
questionnaires, depression (Patient Health Questionnaire-9), and other mental health measures were collected.
Results: The majority of respondents felt HeadGear was easy to use (92%), easily understood (92%), were satisfied with the
app (67%), and would recommend it to a friend (75%; stage 1). Stage 2 found that compared with baseline, depression and anxiety
symptoms were significantly lower at follow-up (t30=2.53; P=.02 and t30=2.18; P=.04, respectively), days of sick leave in past
month (t28=2.38; P=.02), and higher self-reported job performance (t28=−2.09; P=.046; stage 2). Over 90% of respondents claimed
it helped improve their mental fitness, and user feedback was again positive. Attrition was high across the stages.
Conclusions: Overall, HeadGear was well received, and preliminary findings indicate it may provide an innovative new platform
for improving mental health outcomes. Unfortunately, attrition was a significant issue, and findings should be interpreted with
caution. The next stage of evaluation will be a randomized controlled trial. If found to be efficacious, the app has the potential to
reduce disease burden and improve health in this at-risk group.
(JMIR Mhealth Uhealth 2018;6(12):e11661)   doi:10.2196/11661
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Mental health conditions, and depression specifically, are
leading causes of long-term disability globally [1,2]. Such
disorders curtail and prohibit an individual’s participation in
basic activities of life including work [3]. The workplace has a
complex relationship with mental well-being, as it is associated
with both positive (eg, life satisfaction, personal autonomy, and
confidence) [4,5] and negative mental health outcomes (eg,
strain, stress, injury, and illness) [6]. Harvey et al’s [7] model
of psychosocial workplace risk factors highlights the complex
relationship between work and the development of mental health
problems as well as the potential for administering psychological
interventions in the workplace. With recent Australian data
indicating disability support payments for psychiatric conditions
are on the rise with these conditions now being the leading cause
of sickness absence [8], the development of effective
interventions is a pertinent concern.
Due to the predominate role work has in individuals’ lives, the
workplace is increasingly being recognized as presenting a
unique opportunity for both prevention and treatment of mental
ill-health [9]. Although work strain is present across all
industries, certain job-related factors make the issue more
pertinent in some. Employees in male-dominated industries
(MDIs; ie, those in which ≥70% workers are male, eg,
agriculture, construction, mining, manufacturing, transport, and
utilities [10]) have been found to be at heightened risk of mental
health conditions [11,12]. This is likely due to a combination
of job-related factors (eg, seasonal employment fluctuations
leading to job insecurity, remote or isolated locations and family
separation, and highly competitive, high-pressure work
environments) [12] and the sociodemographic features of the
employees themselves (eg, alcohol and substance abuse, low
mental health literacy, and low rates of help seeking [13,14]).
Related to—and compounding—both these areas is a traditional
male attitude and workplace culture that has historically valued
concepts of toughness, stoicism, and self-reliance [15,16].
Despite this need, little work has been specifically aimed toward
these at-risk employees, with conventional prevention programs
being poorly utilized by—or tailored to—these groups [17].
Electronic health (eHealth) and specifically mobile health
(mHealth; health care practices supported by internet or mobile
phone technologies) provide an opportunity to overcome some
of the barriers present in traditional approaches to prevention
and treatment [18]. Recent evidence suggests such interventions
have utility in improving mental health outcomes in general
[19-21], whereas workplace reviews have found eHealth
interventions are effective at improving workers’ psychological
well-being, increase work effectiveness [22], and mental health
and stress symptoms [23]. Although the dominant therapeutic
approach in this area is cognitive behavioral therapy, there is
increasing evidence that mindfulness and other approaches may
hold distinct utility in this space [22-24]. Furthermore, the high
rates of smartphone ownership increase the viability of mobile
mental health care interventions [25]. However, this area is still
in its infancy and little is known about the feasibility of such
approaches in MDIs specifically.
Considering these findings and gaps in the knowledge base, we
sought to develop a smartphone-based workplace intervention
to reduce depressive symptoms and promote well-being, with
a specific focus on MDIs. This paper presents a methodological
framework, based on that of the Medical Research Council
(MRC) [26]; elucidates the development and initial testing of
the app; and details the 2-staged testing approach to finalizing
the development of the program.
The aim of this study is to evaluate the usability, acceptability,
feasibility, and preliminary efficacy of a newly developed app




The model used to develop the app involved a process of
research and analysis, development, implementation, and
evaluation. In developing new technologies, it was important
that the framework was systematic (clear steps following a
logical order), systemic (all processes critical for success are
incorporated), reliable (steps are clearly described so that they
can be replicated by other designers in other projects), iterative
(the cycle of analysis design development testing revision can
be repeated a number of times), and empirical (data gathering
is built into the process and decisions are made on the basis of
data) [27]. The development process utilized a 3-step approach
based on the intervention mapping protocol [28]. Similarly,
processes have been used successfully for mHealth app-based
interventions [29]. The predominate emphasis of this paper is
that of the third step, as other steps have been reported elsewhere
[30,31].
Employees in MDIs were specifically targeted. The process
took place from January 2016 to April 2017. An interdisciplinary
team of computer engineers, psychiatrists, psychologists, and
design experts (user experience and graphic designers)
collaborated in the design and development of the app.
Step 1: Defining the Problem
Although the effectiveness of eHealth and mHealth technologies
for treating moderate levels of mental ill-health in general and
clinical populations has been established, less is known about
workplace eHealth interventions and eHealth prevention. The
problem led the team to conduct a series of systematic reviews
and meta-analyses to determine the effectiveness of workplace
interventions for common mental disorders (CMD) [32],
workplace depression prevention [33], the use of eHealth for
prevention of CMD in general populations [34], and the use of
eHealth tools for CMD in the workplace [23].
A recent meta-analysis of work-based depression prevention
programs found such programs to be encouraging, with a number
of different types of work-based interventions, particularly those
based on cognitive behavioral models, demonstrating an ability
to reduce depressive symptoms on unselected working
populations [9].
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Step 2: Participatory Engagement
To develop a relevant and engaging program, it is important to
involve end users in participatory design and user experience
research [35]. This stage comprised several components,
including 6 focus groups (N=60) with industry partners and an
in-depth survey of 1 specific industry partner (N=105). The
findings of these are reported separately [30,31], and following
feedback, we aimed to design and prototype an app that is
engaging for men in the target workplaces.
Step 3: Design and Pilot Testing
Building on the outcomes of the initial 2 steps, the app content
and design were finalized. The pilot testing of the app involved
a 2-stage approach to test both initial utility and acceptability
(using an alpha version [acceptance testing] of the app) and
feasibility (engagement and perceived usefulness to users) and
preliminary efficacy (using a beta version [operational testing]
of the app). There were several reasons for this approach.
Primarily, the costs involved in the creation of such technology
are considerable. During the participatory engagement step, no
prototype was used to generate unbiased input. However, it was
necessary to be able to make modifications based on this testing
and the usability of the app. Subsequently, modifications were
made to the app between the 2 (alpha or beta) stages of the
design and pilot testing step to refine usability elements and to
test preliminary efficacy.
The App
HeadGear is a smartphone app–based intervention centered on
behavioral activation and mindfulness therapy. The main
therapeutic component of the HeadGear app takes the form of
a 30-day challenge in which users’ complete 1 challenge daily
(approximately 5-10 min; Figure 1). These challenges include
psychoeducational videos on coping skills or resiliency,
mindfulness, and behavioral activation; mindfulness exercises;
value-driven activity planning, goal-setting, and review; and
coping skill development (problem solving, sleep, grounding,
alcohol use, assertiveness, and training in adaptive forms of
coping). The inclusion of these specific components was driven
by the findings of stages 1 and 2 (specifically, [9,23,30,31,34]).
The first daily challenge involves the completion of a risk
calculator, which assesses and provides participants with
personalized feedback regarding their risk for future mental
health issues. The risk calculator consists of 20 items developed
from the Household, Income and Labour Dynamics in Australia
Survey (HILDA) and has been validated in the Australian adult
population [36]. The risk factor items are based on participant
self-report. The HILDA risk items include age, gender,
Aboriginal and Torres Strait Islander status, active career status,
freedom to decide work, satisfaction with hours worked,
satisfaction with employment opportunities, physical activity,
alcohol use, episodes of distress in the previous 2 years,
satisfaction with health, satisfaction with the neighborhood,
satisfaction with partner, satisfaction with the way tasks are
divided with partner, having someone to confide in, the feeling
of being pushed around, and English as a second language. The
HILDA questions and response items were replicated from the
original items included in the HILDA survey, apart from age,
which is measured here as a continuous measure. Users received
personalized risk feedback immediately after completing the
risk calculator. The personalized risk feedback involves an
interactive icon array, which displays the calculated numerical
risk estimate of developing anxiety and depression within the
next year, along with a text description (Figure 2). Although
much of the app is not specific to a workplace (or even MDI)
setting and is likely to have utility to a general population, it
was within these populations that development occurred. The
outcomes of early development work [30,31] led to the inclusion
of certain elements, determined to be the most relevant among
these groups. Importantly, the risk algorithm was built from a
working population sample and was fundamental to its working
population delivery.
Other components of the app include a mood monitoring widget,
a toolbox of skills (which is built from the challenges as they
are completed), and support service helplines. Users had access
to the app indefinitely. The app monitors use time and frequency
and mission completion rates.
Stage 1: Alpha Testing—Utility and Acceptability
Participants
Participants (N=21) were recruited via email circulation and
snowball recruitment from 3 industry partner organizations
(agriculture, freight or postage, and mining). Study eligibility
included Australian residency, aged between 18 and 65 years,
valid email, ownership of an Apple- or Android-operating
smartphone, ability to comfortably read English, and current
employment. Consent was obtained electronically from all
participants, and any identifiable data were encrypted to ensure
confidentiality. The study acted in accordance with the Helsinki
Declaration.
Procedure
Interested individuals were directed to the program’s website
to undergo screening and provide informed consent via the
Web-based participant information statement. Participants
completed a baseline questionnaire and were then invited to
download the app. As an alpha version, iPhone users were
required to download the app via a third-party app Testflight.
Participants were encouraged to use the app for 30 days as often
as they wanted. At the end of this period, users completed a
follow-up questionnaire within the app (with 2 reminder emails
sent to noncompleters). Daily engagement in the intervention
was not incentivized, but successful completion of the posttrial
questionnaire placed participants in the draw for an Aus $300
gift voucher. The study was approved by the University of New
South Wales (UNSW) Human Research Ethics Committee (HC
No: 16646).
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Figure 1. Intervention component of the HeadGear app: the 30-day challenge (left), a behavioral activation day (middle), and a mindfulness day (right).
Figure 2. Additional features of the HeadGear app: mood widget (left), toolbox (middle), risk feedback (right).
Measures
Participants completed self-administered questionnaires within
the app. Demographic information provided included age, sex,
education, occupation, role, location, and industry group. The
follow-up survey comprised the same measures as in the initial
battery with the addition of a 26-item acceptability and usability
questionnaire (comprising adapted items from the System
Usability Scale [37]; Post Study System Usability Questionnaire
[38]; Technology Assessment Model Measurement Scales [39];
and Usefulness, Satisfaction, and Ease questionnaire [40]), and
this blended tool has been used successfully in previous research
[41]. Participants were asked to rate their agreement with a
series of statements about the intervention. Usage data were
automatically collected by the app including time spent in app,
number of logins, and specific responses to exercises.
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Stage 2: Beta Testing—Feasibility and Preliminary
Efficacy
Participants
Participants (N=84) were recruited via Facebook advertisements.
All the advertisements were targeted (using Facebook’s
advertising platform) to males aged between 18 and 65 years,
located within Australia, and employed in an MDI. Facebook
allowed targeting of the following industries: agriculture,
engineering, transport, forestry, mining, plumbing, and
construction. Inclusion eligibility criteria were the same as those
in stage 1.
Procedure
The advertising campaigns all ran simultaneously between July
and August 2017. Advertisements were restricted to be shown
only on mobile devices. Clicking anywhere on the Facebook
advertisement directed interested individuals to the study website
where they completed consent electronically. Confidentiality
was assured via data encryption. After giving consent,
individuals were asked to provide a mobile phone number. This
number was verified by sending it a short message service
(SMS) text message containing a random 4-digit code, which
the individual was required to enter on the study website to
continue. After a successful verification, the individual was sent
(via SMS text message) a link that allowed them to download
the HeadGear app via the Google Play or iOS app store,
depending on their device. Participants then proceeded to an
in-app questionnaire that collected demographic information
and contained a number of study-specific measures (see below).
At 5 weeks post baseline, participants were sent a text message
(with 2 reminder texts sent to noncompleters), which directed
them to the study data-collection site, and responded to a similar
questionnaire (with the removal of demographic items and
inclusion of some program feedback questions). Postintervention
assessment occurred at 5 weeks post baseline to allow users 1
extra week to complete the 30-day program.
Daily engagement in the intervention was not incentivized, but
successful completion of the posttrial questionnaire placed
participants in the draw for a Aus $200 gift voucher. The study
was approved by the UNSW Human Research Ethics Committee
(HC17021).
Measures
The Patient Health Questionnaire-9 (PHQ-9) was used to
measure depression symptoms [42]. The PHQ-9 is a reliable
and valid 9-item measure of depression severity over the past
2 weeks [42,43]. Each of the 9 items of the PHQ-9 is scored as
0 (not at all), 1 (several days), 2 (more than half the days), or 3
(nearly every day). As a screening tool, summing the 9 item
leads to a maximum score of 27 indicating all symptoms
occurring nearly daily. The criterion and construct validity of
the PHQ-9 have previously been demonstrated, with 73%
sensitivity and 98% specificity in detecting major depression
compared with clinician-based assessment [42,44], and
regardless of diagnostic status, it typically represents clinically
significant depression [42]. The measure has demonstrated
excellent internal consistency (Cronbach alpha >.85 in multiple
samples) and test-retest reliability of .84 [43].
Anxiety was measured using the 2-item Generalized Anxiety
Disorder (GAD-2) scale [45]. The GAD-2 consists of the 2 core
criteria for generalized anxiety disorder, which have also been
shown to be effective screening items for panic, social anxiety,
and posttraumatic stress disorders [45]. Equivalent to the parent
scales, the PHQ-2 begins with the following stem question:
“Over the last 2 weeks, how often have you been bothered by
the following problems?” Response options are “not at all,”
“several days,” “more than half the days,” and “nearly every
day,” scored as 0, 1, 2, and 3, respectively (total ranging from
0 to 6). Scale scores of 3 or above are suggested as cut-off points
between the normal range and probable cases of anxiety [45].
Resilience was measured by the Connor Davidson Resilience
Scale (CD-RISC), a 10-item self-report scale demonstrated to
be psychometrically sound with high internal consistency
(Cronbach alpha=.89), construct validity, and test-retest
reliability in the general population and in clinical settings [46].
Total scores range from 0 to 40 with higher scores corresponding
to greater resilience. Validity is highly relative to other measures
and reflects differentiation in resilience among diverse
populations, showing that higher levels of resilience are
consistent with lower levels of perceived stress vulnerability
[46]. The CD-RISC has been shown to differentiate between
individuals who function well after adversity from those who
do not and measures the core features of resilience and the
ability to tolerate experiences [47]. It is believed that increased
resilience may reduce rates of mental ill-health [48].
Well-being was assessed using the 5-item World Health
Organization Well-Being Index (WHO-5) [49,50]. Raw scores
range from 0 to 25, where 0 indicates the worst possible quality
of life and a score of 25 represents the best possible quality of
life. A score less than or equal to 13 or an answer of 0 or 1 on
any of the 5 items shows poor well-being. WHO-5 is a
psychometrically sound measure of well-being with high internal
consistency (Cronbach alpha=.84) and convergent associations
with other measures of well-being [51].
Work performance was assessed using a modified version of
the World Health Organization Health and Work Performance
Questionnaire (WHO-HPQ) [52]. The WHO-HPQ is a
self-report instrument designed to estimate the workplace costs
of health problems in terms of self-reported sickness absence
and reduced job performance (presenteeism). The absolute
presenteeism score derived from this tool ranges from 0 (total
lack of performance during time on the job) to 100 (no lack of
performance during time on the job) with higher scores
indicating less presenteeism. Absolute presenteeism was
calculated, given it has been associated with better construct
validity than the relative measure [53].
The WHO-HPQ was modified to simplify the absenteeism
measure. Short-term absenteeism was assessed by asking “how
many days/shifts have you missed over the past 4 weeks (28
days) due to sickness absence.” If greater than 0, respondents
were then asked, “how many of these sick days were due to
mental health or emotional problems.” For long-term
absenteeism it was asked, “over the last 6 months have you had
a continuous 1-week period of sickness absence.” Following
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this question respondents were asked, “if yes, was this due to
mental health or emotional problems?”
Statistical Analysis
Sample Size
For stage 1, 25 individuals were sought to review the program.
This number is not based on traditional power analysis
calculations as our descriptive design precludes the ability to
carry out power analyses. For this reason, we have drawn on
previous studies in the field to guide in sample size
determination.
Pilot studies (stage 2) tend to be underpowered to determine
proof-of-concept. Additionally, the large sample size required
for universal prevention work contribute to a lack of power in
such pilot trials [54]. Despite this, for stage 2, using a 2-tailed
test, with alpha set at P=.05 and power level of .80 (to detect a
medium effect), a total of 40 participants was required. Due to
expected high rates of dropout due to the unguided eHealth,
general population, and nature of the study, an attrition rate of
50% was selected and a sample size of 80 was set.
Analysis Plan
All data were analyzed using IBM SPSS version 23.0 [55].
Stage 1 presents only descriptive statistics. In stage 2, descriptive
statistics derived from participants’ smartphone use data were
used to characterize engagement and acceptability in the pilot
study. Paired sample t tests were used to test for differences
between pre- and posttrial clinical outcomes (eg, PHQ-9).
Symptom change scores were computed, and linear regression
was performed to test for the effect of time spent using the app,
level of baseline risk, or the industry of employment on
symptom change. Standardized effect sizes (Cohen d [56]) were
calculated for outcomes of interest following the methods
reported in the study by Lipsey and Wilson [57].
Results
Stage 1: Alpha Testing
In total, 21 participants downloaded the app, 12 of whom
responded to the follow-up survey. However, 6 participants
consented but did not download the app and were subsequently
removed from the study. The average age of the participants
was 37.86 years (SD=10.98); approximately half of the
participants were female (n=12). The majority of the sample
worked in freight and postage (n=11), followed by mining (n=6)
and agriculture (n=2); however, 3 participants declined to
provide their industry. Approximately half of the participants
were working in a manager role (n=9) and the majority were
based in an urban center (n=15).
Utility
Participants on average completed 5.71 challenge days
(SD=9.02) and logged an average of 3.33 (SD=5.48) moods.
Participants were asked to rate their agreement with a series of
statements about the app’s utility (see Table 1). Over 90% of
participants reported that they believed most people would learn
to use the app quickly and were satisfied with how easy the app
was to use. Over 80% were comfortable using the app. The
majority of negative feedback received came from 1 participant
who only used the app to log 1 mood.
Acceptability
Table 2 shows respondents’ rating of the app’s acceptability.
Over 90% of participants reported that they believed the
information was easily understood and over 80% felt confident
using the app. No respondent felt they needed to learn a lot of
things before using the app. Over two-thirds of respondents
were satisfied with the app, whereas 75% claimed it was fun to
use, interactive, and that they would recommend it to a friend.
Again, only 1 user reported substantial negative responses.
There was a degree of concern about the utility of the app with
only 40 to 50% of respondents claiming they would use it, or
use it often, and 42% claiming the app worked the way they
wanted it to. However, few actively disagreed with these
statements.
Table 1. App utility questionnaire.
Agree, n (%)Neutral, n (%)Disagree, n (%)Statement
2 (17)0 (0)10 (83)I think that I would need the support of a technical person to be able to use the app
8 (67)3 (25)1 (8)I found that the different parts of the app work well together
1 (8)4 (33)7 (58)I thought there was too much inconsistency in the app
11 (2)0 (0)1 (8)I would imagine that most people would learn to use the app very quickly
2 (17)0 (0)10 (83)I found the app very awkward to use
11 (92)0 (0)1 (8)Overall, I am satisfied with how easy it is to use the app
8 (67)2 (17)2 (17)I was able to complete the “modules” quickly in the app
10 (83)1 (8)1 (8)I felt comfortable using the app
9 (75)0 (0)3 (25)Whenever I made a mistake using the app, I could recover easily and quickly
9 (75)2 (17)1 (8)How things appeared on the screen was clear
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Table 2. App acceptability questionnaire.
Agree, n (%)Neutral, n (%)Disagree, n (%)Statement
5 (42)6 (50)1 (8)I think that I would like to use the app often
1 (8)3 (25)8 (67)I found the app to be very complicated
10 (83)1 (8)1 (8)I felt very confident using the app
0 (0)1 (8)11 (92)I needed to learn a lot of things before I could get going with the app
11 (92)0 (0)1 (8)The information provided for the app was easy to understand
6 (50)5 (42)1 (8)If I have access to the app, I will use it
8 (67)3 (25)1 (8)I am satisfied with the app
9 (75)2 (17)1 (8)I would recommend the app to a friend
9 (75)2 (17)1 (8)The app is fun to use
7 (58)3 (25)2 (17)The app helped me manage my symptoms
9 (75)2 (17)1 (8)The app was interactive enough
Table 3. Demographics and app usage (N=84).
StatisticsCharacteristics
38.62 (9.23)Age in years, mean (SD)
84 (100)Male, n (%)
48 (79)Prior episode of mental ill-health, n (%)
58.24 (63)Total active time in minutes, n (%)
9.11 (10)Challenges completed, n (%)
15.03 (16)Days used, n (%)
Industry, n (%)
37 (45)Male-dominated industrya
45 (54)Nonmale dominated industry





2 (2)Role not provided
Risk category [36], n (%)
10 (12)Low (≤4.5%; up to 25th percentile)
21 (251)Average (4.6%-22%; 25th to 90th percentile)
30 (35)High (≥23%; above 90th percentile)
aAgriculture or forestry or fishing, manufacturing, wholesale trade, mining, construction, other manual trade, transport or postal or warehousing, and
first responder or defense or security.
Changes
A number of functionality and user interface and experience
issues were resolved between stage 1 and 2. Additionally,
changes were made to the app based on individual feedback.
This included improved risk feedback (to better explain the
feedback and direct users to elements in the challenge or external
help), reminder functionality, a new booster session video added,
goal-setting changes (to link values to both small and larger
goals), and improvements to the skill toolbox (allowing for
better integration with the challenge).
Stage 2: Beta Testing
The sample was entirely male, with almost half working in an
MDI (Table 3). Participants had a mean age of 38 years
(SD=9.23). On average, participants spent just under an hour
in the app (mean=58.24 min; SD=62.98) and completed a third
(mean=9.11; SD=10.25) of the challenge days. Over half (n=48)
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of the participants reported a prior episode of mental ill-health
and were considered high-risk on the HILDA-derived risk
algorithm [36].
Preliminary Effectiveness
Although usage data were collected on all participants, only 34
(40.5%) completed follow-up questionnaires. No differences
were found on any baseline data collected between responders
and nonresponders; however, those responding to follow-up
completed significantly more challenges (t54.23=4.12; P<.001),
app sessions (t41.62=3.22; P=.002), and active time (t41.49=3.38;
P<.002). At 5-week follow-up, the HeadGear app was
associated with significant reductions in depression symptoms
(t30=2.53; P=.02; Cohen d=0.39), anxiety symptoms (t30=2.18;
P=.04; Cohen d=0.38), and overall past month sick days
(t28=2.38; P=.02; Cohen d=0.22) and increases in self-reported
workplace productivity (t28=−2.09; P=.046; Cohen d=0.33).
Trends toward improvement were found for well-being and
mental health sick days, although these did not reach
significance (Table 4).
Further analysis was conducted to determine whether
improvement in depression and anxiety symptomatology was
related to app usage. The results showed that there was a
significant association between change in depression symptoms
and time spent using app (F1,31=6.08, P=.02; R
2=.164).
Similarly, there was also a significant association between
change in anxiety (F1,29=5.35, P=.03; R
2=.174) and well-being
(F1,30=4.15, P=.049; R
2=.121) and time spent using the app.
These results suggested that more time spent using the app was
associated with a greater reduction in depression and anxiety
symptomatology and a greater improvement in well-being. No
other comparisons reached significance. Additional analysis
indicated that the change in depression and anxiety
symptomatology was not related to participants’ level of risk
category or industry type.
Feasibility and Feedback
Figure 3 presents the basic feasibility of the program (n=34).
Over three quarters (76%) of the respondents found the app to
be mostly or completely appropriate for them, over 90% claimed
it helped them improve their mental fitness (at least somewhat),
and 90% found it mostly or completely understandable. Users
were asked about the best and worst features of the app (stability,
speed, look and feel, functionality, navigation, content, and
other). Content was the most popular feature reported (46%),
followed by both look and feel and functionality (23%).
Navigation was the most highly ranked issue with the app (23%).
Table 4. Effectiveness outcomes. Italics indicates significance at the .05 level.
SignificancePosttrial, mean (SD)Pretrial, mean (SD)Outcome measure
.029.68 (5.86)12.00 (5.93)Patient Health Questionnaire-9
.4710.00 (5.45)9.29 (4.26)5-item World Health Organization Well-Being Index
.7523.27 (8.13)23.57 (7.32)Connor Davidson Resilience Scale
.042.16 (1.63)2.77 (1.61)2-item Generalized Anxiety Disorder
.04663.10 (20.20)53.79 (28.34)Absolute presenteeisma
.021.24 (3.06)2.31 (4.86)Sick days past month
.100.90 (2.85)1.59 (4.87)Mental health sick days past month
aA score of self-reported workplace productivity (higher scores=greater productivity).
Figure 3. HeadGear pilot beta feedback (n=34).
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Open feedback on the app was generally positive, with
mindfulness and value-based goal setting highly regarded:
Improved my focus to make mindfulness a more
consistent part of my day.
Great app has really helped me look at all aspects of
my life: work, relationships, interests, exercise, diet
and mindfulness. This app has helped me manage my
anxiety and depression.
However, engagement and personal commitment were
consistently raised as issues:
I wasn't able to sustain engagement with it. This was
mostly through having some really good days. My
mental health is constantly fluctuating. I think the
content I saw was really good and I think if I had the
time (didn't work so much) and was in a worse way
[sic] would've used it more consistently.
Some users reported disengaging from the longer challenges:
Disengaged from longer sessions, feeling like I wasn't
acting on set actions without consequence.
While creating time was also an issue:
I didn’t make enough time to complete it,
(You need to) Break up long sessions/ (have) time
limited options.
Only 8 respondents wanted to see additional features in the app;
these features included a sleep tracker, ability to download and
print, rescheduling of reminders (already present in the app),




This study provides both a framework for the development and
testing of a new smartphone app intervention, HeadGear, and
investigates the use and acceptability, along with the feasibility
and preliminary effectiveness, of the app in a working
population, specifically MDIs. The core features and
functionality of the app were developed through a participatory
design process, and the content of the app was based on current
best available evidence-based theory. The research team
encompassed computer engineers, psychiatrists, psychologists,
and design (user experience and graphic design) experts allowing
for a multidisciplinary approach to development. The pilot
testing of the app incorporated a 2-stage process that utilized
different samples and different outcomes measures to reflect
the progression of the app from alpha to beta testing. Overall,
the app was well received in both stages of the pilot testing, and
preliminary testing indicated significant improvements in
measures of psychopathology and workplace productivity.
The results from this feasibility and efficacy pilot trial suggest
that an mHealth app can be an engaging, useful, and acceptable
intervention. Across the 2 stages of the study, the majority of
the participants acknowledged the utility, helpfulness, and
overall ease and acceptability of use of the HeadGear app. With
regards to preliminary efficacy of the intervention, the results
are in line with previous findings that have shown mindfulness
and behavioral activation to be effective in the treatment of
mood and anxiety disorders [58,59], even in mobile app forms
[24]. The dose-effect response seen between level of usage of
the HeadGear app and improvements in both depression and
anxiety symptoms was also encouraging; however, due to high
attrition, findings need to be interpreted with caution.
Although improvements in well-being and resilience were found,
these findings were not significant. As the sample included both
well and unwell individuals, it is likely to have been
underpowered to detect such changes; this underscores the need
for a full-scale efficacy trial. Results also indicated that there
were significant reductions in absenteeism and increases in
worker productivity. This is especially encouraging given
medical interventions in isolation have not shown as positive
an effect on work-related outcomes when compared with
workplace interventions [60]. This finding suggests the utility
in incorporating evidence-based interventions in the workplace.
Strength and Limitations
Despite the positive reviews of stage 1, there was a low level
of challenge days completed. This may reflect a number of
functionality issues resolved for stage 2 and that the sample’s
characteristics were not representative of MDIs (from which
this sample was taken and for which the app was designed) as
50% of participants were women. When contrasted with a
technically improved iteration and a more representative
population (stage 2), there was significantly more engagement
with the app. Nevertheless, engendering motivation to complete
the program was a concern raised in this review process.
Although reasons for disengagement are complex and rarely
only due to dissatisfaction [61] and somewhat unsurprising
given the unguided nature of the trial [62,63], it does raise some
feasibility concerns. O’Brien and Toms [64] suggest that
engagement is not static but a process operating over a
continuum; therefore, understanding this process more
specifically across each of the challenge days might assist in
improving adherence, which may be garnered through a larger
trial. It was determined in earlier development steps [30,31]
that end users were familiar with month-long health endeavors
(eg, FebFast, Steptember, Dry July), and this played a role in
the selection of the 30-day challenge period. Mobile apps, in
general, suffer from poor rates of retention. Overall, 43% of
global mobile users were still using apps (at least once) 1 month
after download [65]. However, 23% will use an app only once,
and only 1 in 3 will use an app at least 11 times [66]. Ultimately,
this presents new obstacles in regards to engagement with a
mental health and well-being app that need to be considered
over the full intervention [67]. Encouragingly, results indicated
the more time spent in the app was associated with more positive
outcomes on the primary outcome and that participants used
the app irrespective of their current symptom level, suggesting
it has wider appeal than simply those with heightened
symptomatology. Nevertheless, further research is required to
better understand ways in which to enhance engagement.
A substantial strength of the study was the development process,
which allowed for detailed and systematic analysis of a product
in multiple stages of testing. Additionally, the mobile-based
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delivery of the program holds a number of advantages over
traditional methods particularly in MDIs [68]. Despite some
limitations to generalizability, the study indicates that the
intervention may have value in engaging this difficult-to-reach
and at-risk group [69]. Indeed, tailoring the treatment to the
feedback received during participatory user research meant that
goal-directed and skill-based activities were the predominate
focus of the intervention, which is in line with other
recommendations for this group [70].
In addition to modest rates of intervention completion, the
follow-up rate was also a limitation, and as mentioned, this has
implications for the findings. Despite email (stage 1) and SMS
text message (stage 2) reminders and incentives for assessment
completion, follow-up rates were low compared with the
literature [71]. Some reasons postulated for this include the
source of recruitment (social media in stage 2), limited exclusion
criteria (ie, those who were well may have had less motivation
to engage), and a lack of personalized follow-up. However, a
key factor which is unique to this trial is onboarding, whereby
participants downloaded the app, consented, and subsequently
completed baseline within the app. Therefore, users may have
had little desire to participate in the trial but simply wanted
access to the app. In an attempt to streamline the user experience
(avoiding filtering participants through an arduous onboarding,
which may lose all but the most conscientious participants), the
study may, in fact, have recruited a less research-engaged
(though perhaps more real-world) sample. Clearly, alternate
and intensive strategies are required, as these low levels of
retention raise feasibility concerns for a larger randomized
controlled trial (RCT) trial. Additionally, low levels of mental
health sick days were reported in the sample. This is
unsurprising considering the small size and short follow-up;
however, it limits what can be derived from this outcome.
Sample size limited further investigation of change in outcomes
based on baseline risk category or industry; again, larger RCT
studies are required to explore these relationships. An additional
limitation is despite targeting MDIs, there was significant
interest from non-MDIs, and consequently, the conclusions that
can be reached pertaining solely to MDIs are limited; conversely,
the app may have wider utility. Finally, and perhaps most
importantly, the lack of a control group limits any conclusions
that can be made regarding the beneficial impact of this app; an
RCT would help to ameliorate the biases inherent in
uncontrolled trials.
Conclusions
The results from this pilot trial suggest that the HeadGear app
can be an engaging, acceptable, and potentially effective
intervention. Although preliminary results were encouraging,
noted limitations in the pilot design highlight the need for a
full-scale efficacy trial to better understand the utility of
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